• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR REFLEX CATHETER; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR REFLEX CATHETER; CATHETER, PERCUTANEOUS Back to Search Results
Model Number UNK-NV-RFX
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Intracranial Hemorrhage (1891)
Event Date 07/01/2016
Event Type  Death  
Event Description
Zhang j, yu m, lv x.Endovascular treatment of blood blister-like aneurysms of internal carotid artery: stent-assisted coiling and pipeline flow diversion.Journal of clinical neuroscience, 90 (2021) 8-13.Https://doi.Org/10.1016/j.Jocn.2021.04.040.  medtronic review of the literature article found described retrospective study of 27 patients who underwent endovascular treatment with stent-assisted coiling or pipeline flow diversion to treat subarachnoid hemorrhage (sah) due to rupture of internal carotid artery blood blister-like aneurysms from july 2016 through july 2020.A proximal stenosis caused by angiopathology adjacent to aneurysms were found on internal carotid artery angiograms in all 27 cases.The angiopathology combining with the aneurysms implement that acute dissection of the supraclinoid segment of the internal carotid artery indicated the pathogenesis of blood blister-like aneurysm formation.  all aneurysms were treated successfully with alleviation of the adjacent angiopathology after stenting on angiograms.During 1 to 12 months (mean 3.5 months) angiographic followup, complete aneurysm obliteration without adjacent stenosis were found in 25(92.6%) patients.The enterprise stent patient experienced postoperative rebleeding at one week hospital day and the aneurysm was retreated with coils.One lvis patient showed aneurysm recanalization at 3 months follow-up and retreated with coils and another lvis stent.The recurrent rate was 7.4%(2/27) in our patients.There was no recurrent bbla in flow diversion patients.During 1¿12 months (mean 3.5 months) clinical follow-up, favorable clinical mrs 0 and 1 was observed in 23(85.2%) patients, mrs 2 in 3(11.1%) patients and 1(3.7%) death caused by coexisting giant brain arteriovenous malformation rupture.One patient presented with non-occult hydrostatic hydrocephalus.No patient developed clinically significant large vessel vasospasm.Continuous cerebrospinal fluid diversion was performed in the 1 patient presenting with hydrostatic hydrocephalus.
 
Manufacturer Narrative
Related to information reported in regulatory report 2029214-2021-01657.Reported patient age (52 years) is representative of the mean age for all patients included in the study.Reported patient sex (female) is representative of the majority (70.4%) of patients included in the study.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFLEX CATHETER
Type of Device
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key13063708
MDR Text Key282694117
Report Number2029214-2021-01660
Device Sequence Number1
Product Code DQY
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-NV-RFX
Device Catalogue NumberUNK-NV-RFX
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age52 YR
Patient SexFemale
-
-